Zhou Ling, Yan Chunli, Gieling Roben G, Kida Yujiro, Garner Warren, Li Wei, Han Yuan-Ping
Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
BMC Immunol. 2009 Mar 19;10:15. doi: 10.1186/1471-2172-10-15.
Expressed in embryonic development, matrix metalloprotein-9 (MMP-9) is absent in most of developed adult tissues, but recurs in inflammation during tissue injury, wound healing, tumor formation and metastasis. Expression of MMP-9 is tightly controlled by extracellular cues including pro-inflammatory cytokines and extracellular matrix (ECM). While the pathologic functions of MMP-9 are evident, the intracellular signaling pathways to control its expression are not fully understood. In this study we investigated mechanism of cytokine induced MMP-9 with particular emphasis on the role of p21-activated-kinase-1 (PAK1) and the down stream signaling.
In response to TNF-alpha or IL-1alpha, PAK1 was promptly activated, as characterized by a sequential phosphorylation, initiated at threonine-212 followed by at threonine-423 in the activation loop of the kinase, in human skin keratinocytes, dermal fibroblasts, and rat hepatic stellate cells. Ectopic expression of PAK1 variants, but not p38 MAP kinase, impaired the TNF-alpha-induced MMP-9 expression, while other MMPs such as MMP-2, -3 and -14 were not affected. Activation of Jun N-terminal kinase (JNK) and NF-kappaB has been demonstrated to be essential for MMP-9 expression. Expression of inactive PAK1 variants impaired JNK but not NF-kappaB activation, which consequently suppressed the 5'-promoter activities of the MMP-9 gene. After the cytokine-induced phosphorylation, both ectopically expressed and endogenous PAK1 proteins were promptly accumulated even in the condition of suppressing protein synthesis, suggesting the PAK1 protein is stabilized upon TNF-alpha stimulation. Stabilization of PAK1 protein by TNF-alpha treatment is independent of the kinase catalytic activity and p21 GTPase binding capacities. In contrast to epithelial cells, mesenchymal cells require 3-dimensional type-I collagen in response to TNF-alpha to massively express MMP-9. The collagen effect is mediated, in part, by boost JNK activation in a way to cooperate the cytokine signaling.
We identified a novel mechanism for MMP-9 expression in response to injury signals, which is mediated by PAK1 activation and stabilization leading JNK activation.
基质金属蛋白酶-9(MMP-9)在胚胎发育中表达,在大多数成年组织中不存在,但在组织损伤、伤口愈合、肿瘤形成和转移过程中的炎症反应中再次出现。MMP-9的表达受到包括促炎细胞因子和细胞外基质(ECM)在内的细胞外信号的严格控制。虽然MMP-9的病理功能很明显,但其控制表达的细胞内信号通路尚未完全了解。在本研究中,我们研究了细胞因子诱导MMP-9的机制,特别强调了p21激活激酶-1(PAK1)的作用及其下游信号传导。
在人皮肤角质形成细胞、真皮成纤维细胞和大鼠肝星状细胞中,响应肿瘤坏死因子-α(TNF-α)或白细胞介素-1α(IL-1α)时,PAK1迅速被激活,其特征是在激酶激活环中的苏氨酸-212开始,随后在苏氨酸-423发生顺序磷酸化。PAK1变体而非p38丝裂原活化蛋白激酶(MAP激酶)的异位表达损害了TNF-α诱导的MMP-9表达,而其他基质金属蛋白酶如MMP-2、-3和-14则不受影响。已证明Jun氨基末端激酶(JNK)和核因子-κB(NF-κB)的激活对MMP-9表达至关重要。无活性PAK1变体的表达损害了JNK但不影响NF-κB的激活,从而抑制了MMP-9基因的5'-启动子活性。细胞因子诱导的磷酸化后,即使在抑制蛋白质合成的条件下,异位表达的和内源性的PAK1蛋白也迅速积累,这表明PAK1蛋白在TNF-α刺激下稳定。TNF-α处理使PAK1蛋白稳定化与激酶催化活性和p21鸟苷三磷酸酶(GTPase)结合能力无关。与上皮细胞不同,间充质细胞在响应TNF-α时需要三维I型胶原以大量表达MMP-9。胶原效应部分是通过增强JNK激活以协同细胞因子信号传导的方式介导的。
我们确定了一种响应损伤信号时MMP-9表达的新机制,该机制由PAK1激活和稳定化介导并导致JNK激活。